Long Island City, NY, United States of America

Thomas Peter Garner

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University of Manitoba, Albert Einstein College of Medicine. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Peter Garner. Retrieved from https://idiyas.com/inventor/thomas-peter-garner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas P Garner: Innovator in BAX Inhibition

Introduction

Thomas P Garner is a notable inventor based in Long Island City, NY (US). He has made significant contributions to the field of medical research, particularly in the development of small molecule BAX inhibitors. His work focuses on creating compounds that can effectively treat diseases where inhibiting BAX is beneficial, such as cardiovascular disorders.

Latest Patents

Garner holds 1 patent for his invention titled "Small molecule BAX inhibitors and uses thereof." This patent discloses various compounds, compositions, and methods for utilizing these compounds in the treatment of diseases or disorders that require BAX inhibition.

Career Highlights

Throughout his career, Thomas P Garner has worked with prestigious institutions, including the University of Manitoba and Albert Einstein College of Medicine. His research has contributed to advancements in understanding and treating cardiovascular diseases.

Collaborations

Garner has collaborated with notable colleagues such as Felix Kopp and Dulguun Amgalan, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Thomas P Garner's innovative work in BAX inhibition represents a significant advancement in medical research, with the potential to improve treatment options for cardiovascular diseases. His contributions continue to influence the field and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…